By Jill Colvin and Alexandra Jaffe

President-elect Joe Biden on Monday received his first dose of the coronavirus vaccine on live television as part of a growing effort to convince the American public the inoculations are safe.

The president-elect took a dose of Pfizer vaccine at a hospital not far from his Delaware home, hours after his wife, Jill Biden, did the same. The injections came the same day that a second vaccine, produced by Moderna, will start arriving in states. It joins Pfizer's in the nation's arsenal against the COVID-19 pandemic, which has now killed more than 317,000 people in the United States and upended life around the globe.

“I'm ready,” said Biden, who was administered the dose at a hospital in Newark, Delaware, and declined the option to count to three before the needle was inserted into his left arm. “I’m doing this to demonstrate that people should be prepared when it’s available to take the vaccine. There’s nothing to worry about.”

The president-elect praised the health care workers and said President Donald Trump's administration “deserves some credit getting this off the ground.” And Biden urged Americans to wear masks during the upcoming Christmas holiday and not travel unless necessary.

Other top government officials last week joined the first wave of Americans to be inoculated against COVID-19 as part of the largest largest vaccination campaign in the nation's history.

Vice President Mike Pence, House Speaker Nancy Pelosi, D-Calif., Senate Majority Leader Mitch McConnell, R-Ky., and other lawmakers were given doses Friday. They chose to publicize their injections as part of a campaign to convince Americans that the vaccines are safe and effective amid skepticism, especially among Republicans.

Vice President-elect Kamala Harris and her husband are expected to receive their first shots next week.

But missing from the action has been President Donald Trump, who has spent the last week largely out of sight as he continues to stew about his election loss and floats increasingly outlandish schemes to try to remain in power. It's an approach that has bewildered some top aides who see his silence as a missed opportunity for the president, who leaves office Jan. 20, to claim credit for helping oversee the speedy development of the vaccine and to burnish his legacy.

Trump, who in the past has spread misinformation about vaccine risks, has not said when he intends to get the shot. He tweeted earlier this month that he was “not scheduled” to take it, but said he looked “forward to doing so at the appropriate time.”

The White House has said he is still discussing timing with his doctors.

Trump was hospitalized with COVID-19 in October and given an experimental monoclonal antibody treatment that he credited for his swift recovery. A Centers for Disease Control and Prevention advisory board has said people who received that treatment should wait at least 90 days to be vaccinated to avoid any potential interference.

“When the time is right, I’m sure he will remain willing to take it,” White House spokesperson Brian Morgenstern echoed Friday. “It’s just something we’re working through.”

White House press secretary Kayleigh McEnany, however, offered a different explanation for the delay. She told reporters last week that Trump was holding off, in part, “to show Americans that our priority are the most vulnerable.”

“The President wants to send a parallel message, which is, you know, our long-term care facility residents and our frontline workers are paramount in importance, and he wants to set an example in that regard,” she said.

The CDC's Advisory Committee on Immunization Practices has said the Pfizer-BioNTech vaccine, which was the first to receive authorization, “is safe and likely efficacious" for people who have been infected with COVID-19 and “should be offered regardless of history of prior symptomatic or asymptomatic SARS-CoV-2 infection.”

While there is no recommended minimum wait time between infection and vaccination, because reinfection is uncommon in the three months after a person is infected, the committee said people who tested positive in the preceding 90 days "may delay vaccination until near the end of this period, if desired.”

The panel also recommends that those who received Trump's treatment put off vaccination for at least 90 days.

“Currently, there are no data on the safety and efficacy of Pfizer-BioNTech COVID-19 vaccination in persons who received monoclonal antibodies or convalescent plasma as part of COVID-19 treatment," they wrote, recommending that vaccination "be deferred for at least 90 days, as a precautionary measure until additional information becomes available, to avoid interference of the antibody treatment with vaccine-induced immune responses.”

Surgeon General Jerome Adams cited that recommendation on CBS’s “Face the Nation” on Sunday when asked if Trump planned to receive the shot on camera.

“From a scientific point of view, I will remind people that the president has had COVID within the last 90 days. He received the monoclonal antibodies. And that is actually one scenario where we tell people maybe you should hold off on getting the vaccine, talk to your health provider to find out the right time,” Adams said.

But others, including Dr. Anthony Fauci, the nation’s top infectious diseases expert, have recommended that Trump be vaccinated without delay.

“Even though the president himself was infected, and he has, likely, antibodies that likely would be protective, we’re not sure how long that protection lasts. So, to be doubly sure, I would recommend that he get vaccinated,” he told ABC News.

___

Colvin reported from Washington. Associated Press writer Jonathan Lemire in New York contributed to this report.

Share:
More In Politics
All Hands Celebrates Black History Month
All Hands celebrates Black History Month by highlighting achievements in inclusivity and paying homage to those who have fought for equal rights. Rep. Maxine Waters (D-CA) joins Cheddar News to discuss voter suppression; Damali Peterman, CEO of Breakthrough ADR, elaborates on the biggest barriers for Black professionals; Andre Perry, senior fellow of Brookings Institution, dives into student loans and the racial wealth divide; and lastly, BET CEO Scott Mills discusses the company's initiatives for 2022.
Black History Being Made On Capitol Hill
All month long Cheddar News is celebrating Black History Month. In our nation’s capital, Black history is being made right now. cheddar's own Arielle Hixon puts the spotlight on three lawmakers making that happen, Rep. Lauren Underwood (D-IL), Rep. Cori Bush (D-MO), and Sen. Tim Scott (R-SC).
Rep. Maxine Waters on Voter Suppression, SCOTUS During Black History Month
Representative Maxine Waters (D-Calif. 43rd District) joined Cheddar News to talk about the current political climate in America, including efforts to roll back voting rights in multiple states in light of Black History Month. "Why do we have to deal with those who still believe that somehow this country only belongs to the whites of the country and that somehow they have to do everything that they can to undermine our voting and do voters suppression to keep us from being influential and at the table by which to solve problems?" she asked. Waters chided "two Democrats" who she said were stymying attempts to rectify the issue and also spoke on President Biden’s promise to nominate a Black woman to the Supreme Court.
Interest Rates Remain Unchanged Though Hikes Loom
Wall Street saw another volatile day after the Federal Reserve left rates unchanged for now, with plans to raise rates in March at its next meeting in order to ease inflation. Fed Chair Jerome Powell said the Fed has not made decisions on the size of rate increases, adding that the Fed is not trying to get inflation below two-percent. Ken Johnson, CFA and Investment Strategy Analyst explains why Powell thinks that high inflation is a significant threat to the labor market.
Factorial Energy Raises $200 Million to Accelerate Commercialization of Its Solid-State Batteries for Electric Vehicles
Solid-state battery maker Factorial Energy recently raised $200 million in a Series D round led by Mercedes-Benz and Stellantis. Factorial says the funding will be used to accelerate commercial production and deployment of its solid-state battery technology, which the company says is safer, and offers up to 50% more driving range than current lithium-ion technology. Factorial also has joint development agreements (announced in late 2021) with Mercedes-Benz, Stellantis, and Hyundai, three of the top 10 global automotive manufacturers, to commercialize its batteries. Factorial CEO Siyu Huang joined Cheddar News' Closing Bell to discuss.
Load More